{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/29/3319290/0/en/Genmab-Announces-Positive-Phase-3-Results-for-Epcoritamab-Plus-Lenalidomide-in-Patients-with-Relapsed-Refractory-Diffuse-Large-B-Cell-Lymphoma-Demonstrating-Statistically-Significa.html", "message": "News view counter 821250 successfully enlarged"}